The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $88,704,000 definitive, firm-fixed-price contract to Access Bio, Inc. to provide over-the-counter (OTC) COVID-19 tests from September 2023 through March 2025. Access Bio is a minority-owned, for-profit, Asian-Pacific American-owned manufacturer of medical goods. This award is not associated with any set-aside program. Access Bio has previously received other COVID-19 test-related contracts from HHS ASPR and the Defense Logistics Agency, totaling over $662 million. The ASPR office is responsible for coordinating the public health and medical response to disasters and emergencies, including the COVID-19 pandemic response.
Generated 11/13/24, 9:20 AM